FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the use of furansulphonates of formula (I) for inhibiting Mycobacterium tuberculosis transketolase, which can be used in medicine:
where X is -NH- or -O-, R is groups:
EFFECT: novel application of compounds of general formula (I) and their pharmaceutically acceptable salts for effective growth inhibition of tuberculosis.
1 cl, 11 ex, 1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SELECTIVE INHIBITORS OF GLYCERALDEHYDE-3-PHOSPHATEDEHYDROGENASE OF MICROBACTERIA | 2017 |
|
RU2661151C1 |
| QUATERNARY AMMONIUM DERIVATIVES OF 2-AMINOTHIOPHEN-3-CARBOXYLATES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2016 |
|
RU2629369C1 |
| USE OF SULFONATES FOR INHIBITING HUMAN LACTATE DEHYDROGENASE A | 2020 |
|
RU2751003C1 |
| 3-TRIAZENONE INDOLES POSSESSING MYCOBACTERIUM ACTIVITY | 2016 |
|
RU2724334C1 |
| NITRITE-REDUCTASE AS POTENTIAL ANTI-TUBERCULAR TARGET AND METHOD TO DETECT SEVERITY OF TUBERCULOSIS | 2013 |
|
RU2671688C2 |
| ANTITUBERCULOUS VACCINE | 2007 |
|
RU2443773C2 |
| NEW EFFECTIVE THERAPEUTIC TARGET FOR TREATING TUBERCULOSIS | 2008 |
|
RU2474621C2 |
| AROMATIC COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATING AND ANTIPROLIFERATIVE AGENTS | 2003 |
|
RU2386625C2 |
| NOVEL BENZOTHIAZINONE DERIVATIVES AND USE THEREOF AS ANTIBACTERIAL AGENTS | 2006 |
|
RU2395508C1 |
| METHOD FOR INACTIVATION OF DRUG-SENSITIVE AND DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS IN EXPERIMENTAL CONDITIONS IN VITRO | 2018 |
|
RU2702646C1 |
